Evaluating inpatient versus outpatient treatment for chronic depression
DepressionForefront: Costs, Treatment and Change Process for Dysthymia
NA · Modum Bad · NCT04911829
This study is testing whether treating chronic depression in the hospital or at home works better and costs less for people with this condition.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | Modum Bad (other) |
| Locations | 1 site (Vikersund, Buskerud) |
| Trial ID | NCT04911829 on ClinicalTrials.gov |
What this trial studies
This study assesses the cost and effectiveness of inpatient versus outpatient treatment for dysthymia, a form of chronic depression. It aims to understand the therapeutic processes involved in treating this condition by conducting frequent assessments of psychological factors, symptoms, and physiological responses. The research will also evaluate which treatment setting is more cost-effective in alleviating symptoms of dysthymia, given the significant societal costs associated with this disorder. By comparing these two approaches, the study seeks to provide insights into the most effective treatment modalities for patients suffering from persistent depressive disorder.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with persistent depressive disorder who have experienced unsuccessful previous treatments and live within driving distance of the treatment facilities.
Not a fit: Patients currently at risk of suicide, experiencing psychosis, or exhibiting severe emotional instability may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more effective and cost-efficient treatment options for patients with dysthymia.
How similar studies have performed: While there is limited research specifically on dysthymia, studies comparing inpatient and outpatient treatments for depression have shown varying results, indicating that this approach may yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Inclusion criteria will be liberal and similar to clinical practice criteria at the treatment site: Persistent depressive disorder as defined by the diagnostic and statistical manual of mental disorders (DSM5); which includes an International classification of disorders-10 (ICD-10) diagnosis of depression, dysthymia, recurrent depression. unsuccessful previous treatments. living within driving distance from the treatment facilities. Exclusion Criteria: * current suicidal risk, current psychosis, marked emotional instability (i.e. issues with impulsivity), strong paranoid traits, current problems related to heavy substance abuse.
Where this trial is running
Vikersund, Buskerud
- Modum Bad — Vikersund, Buskerud, Norway (RECRUITING)
Study contacts
- Principal investigator: Pål Ulvenes, PhD — Modum Bad
- Study coordinator: Pål Ulvenes, PhD
- Email: pal.ulvenes@modum-bad.no
- Phone: 32749857
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Depression, Cost Benefit Analysis, Psychotherapeutic Processes, Dysthymia, Persistent depressive disorder, Chronic depression, Recurrent depression